middle.news
Nyrada Launches Phase Ia Trial for Neuroprotective Drug NYR-BI03
5:20pm on Sunday 1st of June, 2025 AEST
•
Biotechnology
Read Story
Nyrada Launches Phase Ia Trial for Neuroprotective Drug NYR-BI03
5:20pm on Sunday 1st of June, 2025 AEST
Key Points
HREC approval granted for Phase Ia clinical trial
Trial to assess safety and tolerability of NYR-BI03 in healthy volunteers
Recruitment to start shortly, first dosing by end of March 2025
Final Phase Ia results expected in third quarter of 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nyrada (ASX:NYR)
OPEN ARTICLE